Eli Lilly

This new drug combo can prevent COVID-19 deaths and severe cases

March 10th, 2021

Chris Smith

Neutralizing antibodies are the key immune system components at the center of several COVID-19 therapies, including blood plasma transfusions from survivors, vaccines, and monoclonal antibody drugs. Regardless of how the antibodies are obtained or produced, the principle is the same. These proteins can bind to the spike protein found on the novel coronavirus’s exterior and …

Science

FDA just authorized a breakthrough coronavirus drug that’s proven to save lives

November 11th, 2020

Chris Smith

The FDA just authorized a breakthrough coronavirus drug that has been proven to save lives. Known as bamlanivimab or LY-CoV555, Eli Lilly’s new medicine is a monoclonal antibody drug that can block the virus from infecting cells. The drug has shown efficacy in mild-to-moderate COVID-19 cases and should be administered as early as possible in …

Science

We have bad news about one of the most promising new coronavirus drugs

October 27th, 2020

Chris Smith

A promising drug being developed to treat COVID-19 failed to show efficacy with severe coronavirus cases. Eli Lilly announced that it has terminated a study evaluating the efficacy of the monoclonal antibody drug in hospitalized patients. ”Bamlanivimab [LY-CoV555] is unlikely to help hospitalized COVID-19 patients recover from this advanced stage of their disease,” the company …

Tech

A promising coronavirus drug trial was just halted for a mysterious reason

October 14th, 2020

Chris Smith

Eli Lilly is seeking emergency authorization approval for a promising coronavirus drug that was found to be an effective COVID-19 therapy. The company has several ongoing clinical trials for its monoclonal antibody drug, including one where the LY-CoV555 compound has been combined with another promising COVID-19 drug called remdesivir. Eli Lilly announced that the clinical …

Science

This is the best news about a coronavirus cure we’ve gotten in weeks

October 7th, 2020

Chris Smith

A company announced clinical trial results for a new type of medicine developed specifically to treat the novel coronavirus. Eli Lilly says the data it has on hand proves that its monoclonal antibodies can significantly reduce viral loads in patients recovering at home, ameliorate symptoms a few days after infection, and prevent visits to the …

Science

Breakthrough coronavirus drug might be approved before vaccines are ready

June 15th, 2020

Chris Smith

A new type of coronavirus treatment might be ready even before the first vaccine candidates are approved. Monoclonal antibody therapies can be used to treat an existing infection and provide temporary immunity. Eli Lilly is one of the companies testing two such potential COVID-19 treatments and thinks the meds could be approved as early as …

Science

A drug that provides temporary coronavirus immunity started human trials

June 1st, 2020

Chris Smith

Companies working on brand new coronavirus drugs meant to treat COVID-19 and provide limited immunity are approaching human trials. Monoclonal antibodies are artificially grown antibodies based on the ones the immune system develops when fighting off the coronavirus infection. Eli Lilly is the first pharmaceutical company to have started human testing, with the Phase 1 …